Technical Analysis for NUZ - Neurizon Therapeutics Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 8 hours ago |
| Down 2% | about 8 hours ago |
| Down 1% | about 8 hours ago |
| 20 DMA Resistance | about 10 hours ago |
| 10 DMA Resistance | about 10 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research, and Pharmaceutical-Epichem segments. The Corporate and Research segment includes corporate overhead expenses. The Pharmaceutical-Epichem segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company was founded on December 2003 and is headquartered in Claremont, Australia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancers Pharmaceutical Industry Drug Discovery Medicinal Chemistry Pharmaceutical Industries Viral Infections
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancers Pharmaceutical Industry Drug Discovery Medicinal Chemistry Pharmaceutical Industries Viral Infections
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.535 |
| 52 Week Low | 0.077 |
| Average Volume | 558,913 |
| 200-Day Moving Average | 0.224 |
| 50-Day Moving Average | 0.197 |
| 20-Day Moving Average | 0.195 |
| 10-Day Moving Average | 0.192 |
| Average True Range | 0.011 |
| RSI (14) | 47.64 |
| ADX | 15.2 |
| +DI | 15.215 |
| -DI | 23.043 |
| Chandelier Exit (Long, 3 ATRs) | 0.196 |
| Chandelier Exit (Short, 3 ATRs) | 0.219 |
| Upper Bollinger Bands | 0.209 |
| Lower Bollinger Band | 0.181 |
| Percent B (%b) | 0.33 |
| BandWidth | 14.374 |
| MACD Line | -0.003 |
| MACD Signal Line | -0.002 |
| MACD Histogram | -0.0007 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.205 | ||||
| Resistance 3 (R3) | 0.205 | 0.200 | 0.203 | ||
| Resistance 2 (R2) | 0.200 | 0.196 | 0.200 | 0.202 | |
| Resistance 1 (R1) | 0.195 | 0.194 | 0.195 | 0.195 | 0.201 |
| Pivot Point | 0.190 | 0.190 | 0.190 | 0.190 | 0.190 |
| Support 1 (S1) | 0.185 | 0.186 | 0.185 | 0.185 | 0.179 |
| Support 2 (S2) | 0.180 | 0.184 | 0.180 | 0.178 | |
| Support 3 (S3) | 0.175 | 0.180 | 0.178 | ||
| Support 4 (S4) | 0.175 |
